Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 37

1.

Course of Quality of Life After Radiation Therapy for Painful Bone Metastases: A Detailed Analysis From the Dutch Bone Metastasis Study.

Westhoff PG, Verdam MG, Oort FJ, Jobsen JJ, van Vulpen M, Leer JW, Marijnen CA, de Graeff A, van der Linden YM; Dutch Bone Metastasis Study Group.

Int J Radiat Oncol Biol Phys. 2016 Mar 29. pii: S0360-3016(16)00344-8. doi: 10.1016/j.ijrobp.2016.03.032. [Epub ahead of print]

PMID:
27315664
2.

The effect of radiotherapy, and radiotherapy combined with bisphosphonates or RANK ligand inhibitors on bone quality in bone metastases. A systematic review.

Groenen KH, Pouw MH, Hannink G, Hosman AJ, van der Linden YM, Verdonschot N, Tanck E.

Radiother Oncol. 2016 May;119(2):194-201. doi: 10.1016/j.radonc.2016.03.001. Epub 2016 Apr 21. Review.

PMID:
27113796
3.

Predictive Value of Six Prognostic Scoring Systems for Spinal Bone Metastases: An Analysis Based on 1379 Patients.

Bollen L, Wibmer C, Van der Linden YM, Pondaag W, Fiocco M, Peul WC, Marijnen CA, Nelissen RG, Leithner A, Dijkstra SP.

Spine (Phila Pa 1976). 2016 Feb;41(3):E155-62. doi: 10.1097/BRS.0000000000001192.

PMID:
26866742
4.

Predictive model for survival in patients having repeat radiation treatment for painful bone metastases.

Chow E, Ding K, Parulekar WR, Wong RK, van der Linden YM, Roos D, Hartsell WF, Hoskin P, Wu JS, Nabid A, Leer JW, Vonk E, Babington S, Demas WF, Wilson CF, Brundage M, Zhu L, Meyer RM.

Radiother Oncol. 2016 Mar;118(3):547-51. doi: 10.1016/j.radonc.2015.10.018. Epub 2015 Oct 26.

PMID:
26515411
5.

[Alarm symptoms of spinal metastases in patients with cancer].

van der Linden YM, Rolf CA, de Graeff A, Dijkstra PD, Kuijlen JM, Taal W.

Ned Tijdschr Geneeskd. 2015;159:A9256. Dutch.

PMID:
26488190
6.

Revisiting classification of pain from bone metastases as mild, moderate, or severe based on correlation with function and quality of life.

Chow E, Ding K, Parulekar WR, Wong RK, van der Linden YM, Roos D, Hartsell WF, Hoskin P, Wu JS, Nabid A, Ong F, van Tienhoven G, Babington S, Demas WF, Wilson CF, Brundage M, Zhu L, Meyer RM.

Support Care Cancer. 2016 Apr;24(4):1617-23. doi: 10.1007/s00520-015-2957-5. Epub 2015 Sep 23.

PMID:
26399406
7.

Considering patient values and treatment preferences enhances patient involvement in rectal cancer treatment decision making.

Kunneman M, Marijnen CA, Baas-Thijssen MC, van der Linden YM, Rozema T, Muller K, Geijsen ED, Stiggelbout AM, Pieterse AH.

Radiother Oncol. 2015 Nov;117(2):338-42. doi: 10.1016/j.radonc.2015.09.005. Epub 2015 Sep 11.

PMID:
26372343
8.

Quality of Life in Relation to Pain Response to Radiation Therapy for Painful Bone Metastases.

Westhoff PG, de Graeff A, Monninkhof EM, Pomp J, van Vulpen M, Leer JW, Marijnen CA, van der Linden YM; Dutch Bone Metastasis Study Group.

Int J Radiat Oncol Biol Phys. 2015 Nov 1;93(3):694-701. doi: 10.1016/j.ijrobp.2015.06.024. Epub 2015 Jun 20.

PMID:
26281825
9.

Effectiveness of Repeat Radiotherapy for Painful Bone Metastases in Clinical Practice: A 10 Year Historical Cohort Study.

Huisman M, Verkooijen HM, van der Linden YM, van den Bosch MA, van Vulpen M.

Clin Oncol (R Coll Radiol). 2015 Aug;27(8):472-8. doi: 10.1016/j.clon.2015.04.005. Epub 2015 May 23.

PMID:
26004238
10.

Molecular phenotype is associated with survival in breast cancer patients with spinal bone metastases.

Bollen L, Wibmer C, Wang M, van der Linden YM, Leithner A, Bünger CE, Jensen AB, Fiocco M, Bratschitsch G, Pondaag W, Bovée JV, Dijkstra PD.

Clin Exp Metastasis. 2015 Jan;32(1):1-5. doi: 10.1007/s10585-014-9685-y. Epub 2014 Oct 31.

PMID:
25359620
11.

Impact of reirradiation of painful osseous metastases on quality of life and function: a secondary analysis of the NCIC CTG SC.20 randomized trial.

Chow E, Meyer RM, Chen BE, van der Linden YM, Roos D, Hartsell WF, Hoskin P, Wu JS, Nabid A, Tissing-Tan CJ, Oei B, Babington S, Demas WF, Wilson CF, Wong RK, Brundage M.

J Clin Oncol. 2014 Dec 1;32(34):3867-73. doi: 10.1200/JCO.2014.57.6264. Epub 2014 Oct 27.

12.

Taking into account the impact of attrition on the assessment of response shift and true change: a multigroup structural equation modeling approach.

Verdam MG, Oort FJ, van der Linden YM, Sprangers MA.

Qual Life Res. 2015 Mar;24(3):541-51. doi: 10.1007/s11136-014-0829-y. Epub 2014 Oct 18.

PMID:
25326332
13.

An easy tool to predict survival in patients receiving radiation therapy for painful bone metastases.

Westhoff PG, de Graeff A, Monninkhof EM, Bollen L, Dijkstra SP, van der Steen-Banasik EM, van Vulpen M, Leer JW, Marijnen CA, van der Linden YM; Dutch Bone Metastasis Study Group.

Int J Radiat Oncol Biol Phys. 2014 Nov 15;90(4):739-47. doi: 10.1016/j.ijrobp.2014.07.051. Epub 2014 Sep 24.

PMID:
25260489
14.

Dexamethasone for the prevention of a pain flare after palliative radiotherapy for painful bone metastases: a multicenter double-blind placebo-controlled randomized trial.

Westhoff PG, de Graeff A, Geerling JI, Reyners AK, van der Linden YM.

BMC Cancer. 2014 May 20;14:347. doi: 10.1186/1471-2407-14-347.

15.

Effect of age on response to palliative radiotherapy and quality of life in patients with painful bone metastases.

Westhoff PG, de Graeff A, Reyners AK, Monninkhof EM, Rodenhuis CC, van Vulpen M, Leer JW, Marijnen CA, van der Linden YM; Dutch Bone Metastasis Study Group.

Radiother Oncol. 2014 May;111(2):264-9. doi: 10.1016/j.radonc.2014.03.017. Epub 2014 Apr 17.

PMID:
24746581
16.

Patterns of retreatment by radiotherapy.

Barton MB, Allen S, Delaney GP, Hudson HM, Hao Z, Allison RW, van der Linden YM.

Clin Oncol (R Coll Radiol). 2014 Oct;26(10):611-8. doi: 10.1016/j.clon.2014.03.008. Epub 2014 Apr 12.

PMID:
24721443
17.

Prognostic factors associated with survival in patients with symptomatic spinal bone metastases: a retrospective cohort study of 1,043 patients.

Bollen L, van der Linden YM, Pondaag W, Fiocco M, Pattynama BP, Marijnen CA, Nelissen RG, Peul WC, Dijkstra PD.

Neuro Oncol. 2014 Jul;16(7):991-8.

18.

Single versus multiple fractions of repeat radiation for painful bone metastases: a randomised, controlled, non-inferiority trial.

Chow E, van der Linden YM, Roos D, Hartsell WF, Hoskin P, Wu JS, Brundage MD, Nabid A, Tissing-Tan CJ, Oei B, Babington S, Demas WF, Wilson CF, Meyer RM, Chen BE, Wong RK.

Lancet Oncol. 2014 Feb;15(2):164-71. doi: 10.1016/S1470-2045(13)70556-4. Epub 2013 Dec 23.

PMID:
24369114
19.

Poor outcomes after whole brain radiotherapy in patients with brain metastases: results from an international multicentre cohort study.

Windsor AA, Koh ES, Allen S, Gabriel GS, Yeo AE, Allison R, van der Linden YM, Barton MB.

Clin Oncol (R Coll Radiol). 2013 Nov;25(11):674-80. doi: 10.1016/j.clon.2013.07.002. Epub 2013 Jul 29.

PMID:
23906722
20.

The assessment of the risk of fracture in femora with metastatic lesions: comparing case-specific finite element analyses with predictions by clinical experts.

Derikx LC, van Aken JB, Janssen D, Snyers A, van der Linden YM, Verdonschot N, Tanck E.

J Bone Joint Surg Br. 2012 Aug;94(8):1135-42. doi: 10.1302/0301-620X.94B8.28449.

PMID:
22844058
Items per page

Supplemental Content

Loading ...
Write to the Help Desk